CAPRICOR THERAPEUTICS, INC. Minimum Net Capital Required for Entity
CAPRICOR THERAPEUTICS, INC. (CAPR) had Minimum Net Capital Required for Entity of $35.00 million as of 2017-06-27, per its 10-Q filed 2017-11-14.
Discontinued › Notes
us-gaap:MinimumNetCapitalRequiredForEntity1 · last filed 2017-11-14
- 2017-06-27: Minimum Net Capital Required for Entity $35.00M.
| Period end | Minimum Net Capital Required for Entity |
|---|---|
| 2017-06-27 | $35.00M 10-Q · filed 2017-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PUMA BIOTECHNOLOGY, INC. (PBYI) | United States | $0.507B | 15.53 |
| ARVINAS, INC. (ARVN) | United States | $0.510B | 58.38 |
| Ovid Therapeutics Inc. (OVID) | United States | $0.487B | -14.41 |
| ASSEMBLY BIOSCIENCES, INC. (ASMB) | United States | $0.481B | -13,053.96 |
| Evolus, Inc. (EOLS) | United States | $0.519B | -13.32 |
| CRESCENT BIOPHARMA, INC. (CBIO) | United States | $0.529B | -5.20 |
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B | |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 | |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |